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PULMONARY ANTIBACTERIAL MECHANISMS AND THE PATHOGENESIS
OF PULMONARY DISEASEt
Chronic obstructive lung disease appears to result more from the cumula-
tive damaging effects of multiple factors on host tissues than from damage
caused by single specific agents. Familial and genetic influences mediated
through specific enzyme defects or metabolic or immunologic abnormalities
are important background determinants; cystic fibrosis and alpha anti-
trypsin deficiency may serve as good examples. Childhood experience with
acute infections, and socioeconomic factors which may lead to less intense
medical attention in lower socioeconomic groupings, appear to play a role
in the development of chronic lung disease. Later on in life, industrial ex-
posures, habits such as diet, smoking, and drinking, and environmental
factors become important. Little is known about the action of meteorological
factors such as heat, cold, barometric pressure and humidity, but certainly
air pollution has a role. Specific acute and chronic diseases of the lungs
and of other organs such as the heart, kidney, and blood vessels may also
be related to the pathogenesis of chronic nonspecific lung disease.
As in other chronic diseases, such as atherosclerosis and chronic renal
disease, there appears to be a long asymptomatic period, symptoms and
objective physical signs appear only late in the course of the disease, and
detection is achieved only after extensive tissue changes have occurred.
Necessary for effective prevention and treatment of chronic lung disease,
therefore, is the identification of the susceptible individual or population,
through uncovering a genetic predisposition or through detecting the
diseased individual in an asymptomatic state and in time for preventive
therapy. It is also necessary to identify and remove at least the major
causative or associative factors. One approach toward these goals is to
study the disease epidemiologically, as has been done extensively for chronic
bronchitis and emphysema in the last ten years. A second approach is to
study the individual case to uncover important causative factors or mechan-
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istic pathways. Thirdly, the study of animal models permits more detailed
work with mechanisms, agents, and their interactions.
The purpose of an animal model is to bring into rational synthesis the
multiple factors that enter into the causation of chronic nonspecific lung
disease. To achieve that purpose a most important requirement is a mean-
ingful measurement, one that is relevant to the pathophysiology of the
lung, one that is quantitatively measurable in vivo so that small changes
in function and not just massive overwhelming changes may be detected,
and one that reflects abnormality in response to the many factors which
epidemiologically have been associated with the pathogenesis of the disease.
The effects on this host mechanism of single etiologic agents in physiologic
levels require study so that specific interactions can be uncovered, but in
addition the effects of multiple simultaneously or sequentially acting agents
must be measured, a step that increases greatly the degree of complexity of
the experiment. Finally, the physiologic interaction of the lung with acute
and chronic diseases in the lung and distant organs of the body requires
evaluation.
The antibacterial activity of the lung has been found to fulfill these
criteria of a meaningful physiologic parameter, which, by its failure, in-
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FIG. 1. Decline in viable S. aureus in lungs of untreated mice.
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duces disease, and whose function mediates pathophysiologic effects of
etiologically associated conditions. This antibacterial activity appears to
rest on pulmonary phagocytic mechanisms, which in turn are central to the
defense of the lung against the general particulate burden of the external
environment, and which function in a region of the lung that reacts readily
to gaseous agents in the environment. This region of the lung, the respira-
tory membrane, is also in intimate contact with the internal milieu, so that
cells in this region should reflect metabolic changes throughout the body.
In this model bacteria are used as the challenge particulate and the micro-
bicidal activity of the lung as its functional index. Animals are exposed to
bacterial aerosols of suitable size in a constant flow exposure chamber. At
intervals after infection the animals are killed and the lungs cultured
quantitatively."'2
The number of viable bacteria found in the lung declines rapidly after
infection and in a logarithmic fashion so that by the end of six hours, ap-
proximately 95 per cent of this particular bacterial aerosol has been dis-
posed of and by 24 hours virtually 100 per cent has disappeared (see Fig.
1).1,2 The disappearance of viable bacteria in the lung could be due either
to mechanical removal of the bacteria by lymphatics or mucociliary stream,
or due to in situ intrapulmonary killing without translocation, or both.
When bacteria were labelled with a radiotracer, the tracer persisted in the
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FIG. 2. Comparison of decline in viable and radiotracer counts of S. aureus in mouse
lung.
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lung as the viable bacterial count declined.8 Thus, the data shown in Figure
2 separate physical clearance mechanisms from in situ microbicidal mecha-
nisms and show that the decline in viable bacteria is due to bacterial killing
within the lung and not physical removal. If viable bacteria were lost by
way of the mucociliary stream or by way of lymphatics, the radioactive
count would have declined at the same rate as the quantitative bacteriologic
count. In fact, it did not; radioactive count decreased by only 20 per cent
in the same four hours.
This intrapulmonary bactericidal activity could be due to the lytic activity
of preformed enzyme, antibody or other substance, or due to active cellular
processes such as phagocytosis. However, the observation that intact but
excised infected lungs showed no bactericidal activity when incubated for
similar time periods (Fig. 3), suggests that preformed bactericidal sub-
stances were not present.' In histologic studies of the infected lungs, the
bacteria appeared within mononuclear cells at the alveolar level of the lung
(Fig. 4).8 By fluorescence methods, the immunofluorescent antigen could
be seen scattered throughout mononuclear cells at the respiratory level of
the lung (Fig. 5).
These data indicate that the in situ bactericidal mechanism in the lung
is a function of alveolar phagocytosis. Therefore, the efficiency with which
this system operates is apparently a measure of the phagocytic capacity or
function of the lung. This physiologic measurement is made in living ani-
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FIG. 3. Changes in numbers of viable S. aureus in incubated buffered suspensions
and excised infected mouse lungs.
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FIG. 6. Phagocytosis of S. albus by rabbit alveolar macrophages in vitro.
mals, but the same phagocytic curve can be reproduced in 'itro by washing
out alveolar macrophages and studying them in suitable preparations
(Fig.6).6
A final piece of evidence that points to the phagocytic mechanism rather
than a clearance mechanism is what happens to bacteria of very closely
related species, for example, Staphylococcus aureus and Staphylococcus
albus. Were these bacteria cleared as particles, the decline of viable organ-
isms should occur at very comparable rates for the two species. However,
the decline in viable Staphylococcus albus occurs at a rate that is about ten
times more rapid than that of the Staphylococcus aureus (Fig. 7).' This
difference would be difficult to explain on the basis of a physical clearance
mechanism. However, it is not at all difficult to explain by a phagocytic
mechanism since it is well known that phagocytes differ in their effective-
ness against different microbial species. The upper curve in Figure 7 shows
the decline in viability of a gram-negative rod, Proteus mirabilis; it is
killed more slowly. If the animal is immunized against this organism a much
faster rate of phagocytic activity occurs (unpublished data.) Again, this is
not at all surprising in a phagocytic model. Studies of phagocytic mecha-
nisms have clearly demonstrated that the presence of specific antibody
418FIG. 4. Location of inhaled S. aureus in mononuclear phagocyte of alveolus in mouse
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FIG. 7. Death rates of three strains of bacteria in mouse lung.
greatly enhances the ability of a cell to take up and thereby kill the bac-
terial particle.7
In chronic pulmonary infection, bacterial multiplication must be under
partial control, as overwhelming bacterial multiplicati'on and invasion fail
to occur. However, in chronic bronchitis a resident flora of bacteria of low
virulence does become established. in normally sterile areas.' Such a finding
suggests that there may have been a shift in the normal host-parasite
equilibrium such that organisms of low virulence may reside in, though not
invade the tissues of, the lower respiratory tract. If sterility of the respira-
tory tissues of the lung in normals is to be explained on the basis of phago-
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FIG. 8. Effect of prolonged hypoxia on the bactericidal activity of mouse lung.
cytic mechanisms, then where a chronic bacterial flora is found in the lower
respiratory tract, as is the case in chronic bronchitis, one must conclude
that the phagocytic mechanism is malfunctioning, although not completely
paralyzed. The data of Figure 8 show that phagocytic function can stabilize
at a partially defective level. In this study on high altitude hypoxia, rela-
tively stable suboptimal levels of phagocytic function were achieved as long
as the animals were kept at the barometric pressure of 380 mm Hg (48
hours). Return of the animals to normal or elevated pO2 resulted in im-
mediate improvement in antibacterial activity.
A variety of substances at different dose levels have stepwise effects on
this phagocytic mechanism.46 Cigarette smoke has been shown to have an
inhibitory effect on pulmonary microbicidal mechanisms in vivo.9 In in vitro
experiments, a dose-response effect on the phagocytic capacity of the alveolar
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FIG. 9. Effect of cigarette smoke on the phagocytic activity of alveolar macrophages.
macrophage is found, such that incremental doses of cigarette smoke pro-
duce stepwise impairment of the phagocytic activity of the cells (Fig. 9).6
There is a long step between demonstrating this kind of in vitro effect and
incriminating cigarette smoke as an agent in chronic bronchitis or chronic
pulmonary disease. However, this demonstration does allow an hypothesis
of a mechanistic relationship between an agent such as cigarette smoke
which is epidemiologically associated with the development of chronic lung
disease and the susceptibility to infection in the lower respiratory tract that
is found in chronic bronchitis. In addition to its many other effects on the
lung, cigarette smoke may at any given time impair the ability of the lung
to defend against bacterial infection, and thereby permit bacteria to multi-
ply in the lung. The improvement in the amount of polymorphonuclear
material and bacterial infection in sputum that frequently follows the cessa-
tion of cigarette smoking may be due to improvement in this phagocytic
function in the lung.
An interesting finding in the chronic infection of chronic lung disease
is that although there is a mixed bacterial flora in the lower respiratory
tract, acute infective exacerbations are usually associated with the multipli-
cation of a single species from that mixed flora, the most common pre-
dominating bacteria being Hemophilus influenzae or Diplococcus pneu-
mjtoniae. The data presented in Figure 7 showed that the three different
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FIG. 10. Intrapulmonary killing of S. aureus & P. mirabilis in mixed & monoinfec-
tion in normal mice.
bacterial species, Proteus mirabilis, Staphylococcus aureus and Staphylococ-
cus albus were killed at distinctly different rates in the lung when each was
given as a mono infection. When S. aureus and P. mirabilis were given
together in a mixed bacterial aerosol the individual bacterial species were
killed at the same rates as they would be in a mono infection (Fig. 10).
There was no synergistic or antagonistic effect of the presence of one
species on the killing of another. The lung responded independently to
each species of the mixed bacterial aerosol.10
Secondly, when animals were exposed to a single bacterial species and
their phagocytic rates under normal circumstances compared with those
under different kinds of test conditions, there were quantitative differences
in the phagocytic rates among specific single exposures such as ethanol
intoxication, hypoxia, or cold stress.8 One test agent had a greater or lesser
effect than another on phagocytic activity. In addition, the magnitude of
the inhibiting effect of a single test substance depended on which bacterial
species was used as the infective challenge. In Figure 11 the height of the
columns represents the percentage of bacteria remaining after a period of
time-four hours-following infection with Staphylococcus albus, Staphyl.o-
coccus aureus, or Proteus mirabilis. When the animal is given ethanol after
infection with the staphylococcal species, killing is impaired but still pro-
ceeds. Killing of Proteus mirabilis, however, is completely inhibited. There-
fore, Proteus mirabilis should multiply in ethanolized animals, in either
422Antibacterial mechanisms GREEN
Treatment
E]1 Untreated
1thanoE 100
100 Hypoxia ; _
o° 10I1 1 .E.
040 ~ ~ ~ ~ @.
Staph: albus Staph: aureus Prot: mirabilis
FIG. 11. Relative effects of ethanol, hypoxia and cold stress on the intrapulmonary
killing of different bacterial strains in mouse lung. (From Ref. 6.)
single infection or mixed infections with these organisms. Experimental
data do in fact show that under these conditions of treatment, it is indeed
the Proteus mirabilis that multiplies.'° These experiments indicate that the
lung possesses its own bacterial selecting system in the sense that it per-
mits a particular bacterial species to emerge from the mixed flora which
may be either resident in the lung as in chronic lung disease, or inhaled or
aspirated into the lung during events such as anesthesia or alcoholic stupor.
Another important area that must be considered in the pathogenesis of
chronic obstructive lung disease is the effect of acute inflammatory pul-
monary disease on this host defense mechanism. Virus infection provides a
pertinent model because of the prominence of viruses as predisposing agents
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FIG. 12. Changes in the bactericidal activity of mouse lung during influenza virus
infection.
to bacterial infection in the lung. An experimental model was adopted in
which mice were infected with influenza virus and at intervals during the
course of the viral infection, the function of the microbicidal mechanism was
assessed (Fig. 12) ." During the acute period of infection when virus and
interferon titers are high and pathology is developing, the lung maintained
its antimicrobial activity. However, by the end of the first week, in the
seven-to-ten-day period, an abrupt drop in the efficiency of this phagocytic
function occurred, a defect that returned just as abruptly to normal after
this brief interval. This is the period when secondary bacterial infections
frequently develop in acute viral diseases in the clinical situation. An im-
portant mechanism in the occurrence of bacterial infections during acute
virus infections may involve this effect of viruses on pulmonary macrophage
activity.
The data of Figure 13 show that different doses of virus give different
patterns of phagocytic inhibition." In a virus infection following low titre
inocula, nothing happened to pulmonary antibacterial activity. However, in
a severe viral infection, the animals died in three days and microbicidal
activity was inhibited early. There was also a pattern of intermediate in-
fection in which impairment was both early and late. This apparent double
peak may indicate either that two distinct mechanisms of the viral effect
exist, or that there is considerable variation among the animals in the
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FIG. 13. Effect of virus inoculum size on the bactericidal activity of mouse lung in
influenza virus infection.
severity of the virus disease, such that some animals show the severe
disease pattern, and some show the milder disease pattern. Interference
with pulmonary bactericidal activity is not limited to influenza virus in-
fection. The effect is also caused by viruses that produce very much less
pathology in the lung-as a matter of fact, no gross pathology-as in the
case of infection with reoviruses.'
Resistance to pulmonary infection is lowered in a variety of organ sys-
tem diseases. It is depressed in heart failure where complications of infec-
tion are common, in renal failure,' and in many clinical situations where
immunosuppressive therapy is given." Here again, through the experimental
model, a mechanistic link was established between renal disease and pul-
monary infection.'5 Acute renal failure was produced both by means of a
fungal pyelonephritis (Fig. 14) and by means of nephrectomy (Fig. 15).
425
I GREENYALE JOURNAL OF BIOLOGY AND MEDICIN Volume 40,April, June,1968
76 94
M Pwybphbric mice
IStandardEtror
FIG. 14. Effect of progressive fungal pyelonephritis
mouse lungs.
on the bactericidal activity of
Depression of the bactericidal activity of the lung resulted that was not
attributable to fungal multiplication in the lung (Fig. 14) or to the effects
of surgery alone (Fig. 15). The extent of this depression was related to
the degree of the renal failure. Using the appropriate organism (Pasteurella
pneumotropica), multiplication of bacteria in the lung occurred either when
the animal was first infected and then nephrectomized or when the animal
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FIG. 15. The effect of bilateral nephrectomy on the bactericidal activity of mouse
lung against S. aureus.
was nephrectomized first and then infected at intervals after the nephrec-
tomy.'8 These data demonstrate that systemic diseases may influence sus-
ceptibility of the lung to bacterial infection through an effect on alveolar
phagocytosis.
It is critical to know whether pulmonary phagocytic activity is abnormal
in chronic lung disease or in a model of chronic lung disease and whether
it would be possible to detect the presence of the disease by measuring
bactericidal function in the lung. In a series of studies of various lung
diseases in rats and mice,"7 significant differences were found in the bac-
tericidal activity of the lung among individual animals with a single disease
and among groups of animals with diseases of differing pathogenesis and
severity. As an example, 28 per cent of rats with chronic bronchiectasis had
significant abnormality in bactericidal values when compared with disease-
free controls. Similar results were found in mice with chronic interstitial
pneumonitis, but severely silicotic animals showed surprisingly little
alteration from normal. In general, this functional abnormality of the lung
did not parallel the extent of anatomic abnormality, but rather appeared to
reflect physiological or metabolic derangements.
In summary, because of its distinct function as an organ of respiration
in intimate contact with the external environment, the lung is equipped
with defensive mechanisms for inactivating or removing inhaled inert or
infectious particles. This paper has been concerned with the inactivating
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mechanisms rather than the removal mechanisms. Inhaled infectious agents,
in contrast to inorganic particles, are unique because they possess an in-
dependent capacity to increase in mass and in number as inorganic dusts
do not. Therefore, it behooves the lung to inactivate bacteria rapidly.
Transport mechanisms in the alveoli and bronchi may have long-range
import for the disposition of the remains of infectious particles, but the
necessity for rapid inactivation of the viability of the living organism places
a premium on the performance of microbicidal mechanisms.
In the noninflamed lung, the primary microbicidal mechanism appears
to be the alveolar macrophage. Unsuccessful performance by this system
leads to microbial multiplication and inflammation. The functional state of
the alveolar macrophage system is apparently influenced by genetic endow-
ment, by prior immunologic experience, by the metabolic state of the host,
by presence of diseases in other systems, by concurrent pulmonary diseases,
and by the simultaneous activity of a large number of exogenous agents
that appear to alter macrophage activity. Factors which alter macrophage
activity may affect its behavior in a highly specific manner, as in specific
immunity, or nonspecifically, as in toxic poisoning. In the latter case, de-
fense against the broad spectrum of, not only infectious, but also non-living
materials may be altered.
The alveolar macrophage appears to be a logical final common pathway
for the expression of genetic, metabolic, biochemical, and immunologic
physiology in its interaction with inert, toxic, or infectious agents of the
external environment. This pathway is important to the defense of the lungs
against infectious agents and may be important in the pathogenesis of
chronic obstructive pulmonary disease.
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